Artara Therapeutics Inc (TARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 564 | 9,371 | 10,813 | 16,763 | 19,371 |
| Marketable Securities | N/A | N/A | N/A | N/A | 2,496 |
| Other current assets | 122 | 0 | 68 | 135 | 0 |
| TOTAL | $764 | $9,648 | $11,495 | $17,933 | $23,236 |
| Non-Current Assets | |||||
| PPE Net | 459 | N/A | 83 | 105 | 263 |
| Other Non-Current Assets | 0 | 0 | 22 | 22 | 22 |
| TOTAL | $459 | $N/A | $105 | $127 | $285 |
| Total Assets | $1,223 | $9,648 | $11,600 | $18,060 | $23,521 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 716 | 394 | 60 | 1,676 | 441 |
| Accrued Expenses | 2,635 | 1,219 | 1,995 | 1,559 | 2,637 |
| TOTAL | $3,351 | $1,613 | $2,123 | $3,370 | $3,078 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,351 | $1,613 | $2,123 | $3,370 | $3,078 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,843 | 490 | 490 | 490 | 481 |
| Common Shares | 3 | 19 | 19 | 19 | N/A |
| Retained earnings | -12,782 | -223,852 | -222,316 | -217,001 | -210,470 |
| Other shareholders' equity | 0 | 21,185 | 21,187 | 21,186 | 21,528 |
| TOTAL | $-2,128 | $8,035 | $9,477 | $14,690 | $20,443 |
| Total Liabilities And Equity | $1,223 | $9,648 | $11,600 | $18,060 | $23,521 |